update on the management of patients with mpns in transformation
Published 3 years ago • 148 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
2:43
the management of advanced phase mpns
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:45
an insight into clinical risk factors for progression in mpns
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
1:46
how would the approval of luspatercept benefit the treatment landscape in myelofibrosis
-
5:19
mpn hero mayra andújar: a guiding light for people with mpns
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:28
how to approach the treatment of younger patients with mpn
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
1:52
aml19 update: improvement in os in patients with npm1-mutated aml treated with flag-ida-go
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:26
the future of jak inhibition for mpns
-
1:08
insights into disease-modifying agents being explored in mpns
-
1:19
what's on the horizon for the treatment of mpns?
-
2:21
the potential applications for immunotherapy in mpns
-
2:13
the future of mpn treatment: exciting agents and targets being investigated
-
2:11
the management of post-mpn aml